These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 6820483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B, Marsden CD, Naylor RJ, Pycock CJ.
    Brain Res; 1976 Dec 10; 118(1):87-113. PubMed ID: 990957
    [Abstract] [Full Text] [Related]

  • 4. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.
    Clarke PB, Jakubovic A, Fibiger HC.
    Psychopharmacology (Berl); 1988 Dec 10; 96(4):511-20. PubMed ID: 3149775
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P, Robbins TW.
    Neuropharmacology; 1985 Jan 10; 24(1):25-31. PubMed ID: 3920545
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B, Marsden CD, Naylor RJ, Pycock CJ.
    Brain Res; 1977 Mar 04; 123(1):89-111. PubMed ID: 300267
    [Abstract] [Full Text] [Related]

  • 11. Striatal and mesolimbic dopaminergic contribution to 3,4-dihydroxyphenylacetic acid sulfate in rat plasma.
    Boudet C, Simon H, Cottet-Emard JM, Dalmaz Y, Peyrin L.
    Eur J Pharmacol; 1986 Feb 11; 121(1):113-8. PubMed ID: 3082654
    [Abstract] [Full Text] [Related]

  • 12. Electrophysiological evidence for non-dopaminergic mesocortical and mesolimbic neurons in the rat.
    Thierry AM, Deniau JM, Herve D, Chevalier G.
    Brain Res; 1980 Nov 10; 201(1):210-4. PubMed ID: 7417833
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Partial protection by desmethylimipramine of the mesocortical dopamine neurones from the neurotoxic effect of 6-hydroxydopamine injected in ventral mesencephalic tegmentum. The role of noradrenergic innervation.
    Herve D, Studler JM, Blanc G, Glowinski J, Tassin JP.
    Brain Res; 1986 Sep 24; 383(1-2):47-53. PubMed ID: 3094831
    [Abstract] [Full Text] [Related]

  • 18. Decreased locomotor and investigatory exploration after denervation of catecholamine terminal fields in the forebrain of rats.
    Fink JS, Smith GP.
    J Comp Physiol Psychol; 1979 Feb 24; 93(1):34-65. PubMed ID: 447888
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Selective disruption of displacement behaviour by lesions of the mesolimbic dopamine system.
    Robbins TW, Koob GF.
    Nature; 1980 Jun 05; 285(5764):409-12. PubMed ID: 6104303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.